GB0706537D0 - Transcutaneous cancer therapeutic - Google Patents
Transcutaneous cancer therapeuticInfo
- Publication number
- GB0706537D0 GB0706537D0 GB0706537A GB0706537A GB0706537D0 GB 0706537 D0 GB0706537 D0 GB 0706537D0 GB 0706537 A GB0706537 A GB 0706537A GB 0706537 A GB0706537 A GB 0706537A GB 0706537 D0 GB0706537 D0 GB 0706537D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer therapeutic
- transcutaneous
- transcutaneous cancer
- therapeutic
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000012830 cancer therapeutic Substances 0.000 title 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0706537A GB0706537D0 (en) | 2007-04-04 | 2007-04-04 | Transcutaneous cancer therapeutic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0706537A GB0706537D0 (en) | 2007-04-04 | 2007-04-04 | Transcutaneous cancer therapeutic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0706537D0 true GB0706537D0 (en) | 2007-05-09 |
Family
ID=38050807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0706537A Ceased GB0706537D0 (en) | 2007-04-04 | 2007-04-04 | Transcutaneous cancer therapeutic |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB0706537D0 (en) |
-
2007
- 2007-04-04 GB GB0706537A patent/GB0706537D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201004403B (en) | Therapeutic cancer treatments | |
| HRP20181385T1 (en) | Targeting abcb5 for cancer therapy | |
| IL199992A0 (en) | Combination therapy | |
| GB0719518D0 (en) | Therapy | |
| IL202287A0 (en) | Therapeutic pyrazolonaphthyridine derivatives | |
| EP2211863A4 (en) | Combination therapy | |
| GB0707556D0 (en) | Treatment for cancer | |
| GB0700284D0 (en) | Combination therapy | |
| EP2473613A4 (en) | Cancer starvation therapy | |
| GB0809046D0 (en) | Cancer treatment | |
| GB0808690D0 (en) | Therapeutic use | |
| GB0706537D0 (en) | Transcutaneous cancer therapeutic | |
| GB0716072D0 (en) | Therapy | |
| GB0700635D0 (en) | Therapy | |
| GB0606703D0 (en) | Transcutaneous cancer therapeutic | |
| GB0612258D0 (en) | Transcutaneous cancer therapeutic | |
| PT2305654E (en) | Therapeutic agent for cancer pain | |
| GB0706538D0 (en) | Cancer therapeutic | |
| GB0710871D0 (en) | Cancer treatment | |
| GB0606702D0 (en) | Cancer therapeutic | |
| GB0612259D0 (en) | Cancer therapeutic | |
| GB0723503D0 (en) | Cancer treatment | |
| GB0700493D0 (en) | Cancer treatment | |
| GB0703963D0 (en) | Therapy | |
| GB0705917D0 (en) | Therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |